634 results
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Rapid-fire - Nightmares in the cathlab - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover intriguing cases featured in the PCR London Valves 2023 course: learn about a rare malfunction in a Mitral TEER device, delve into the complexities surrounding a self-expanding valve TAVI where embolisation poses a threat towards the left ventricle, explore the challenges associated with TAVR in...
Rapid-fire - Challenging TAVI procedures - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI procedures in this session, including: TAVI in a small aortic annulus with chimney stenting, TAVI with ACURATE Neo 2 and coronary protection in a horizontal aorta with low coronary height, simultaneous kissing balloon inflation technique for effective coronary protection during TAVI, and much...
New techniques for commissural alignment
19 Nov 2023 – From PCR London Valves 2023
Learn how to perfect your mastery of commissural alignment with the 3 cases presented in this session, which highlight new techniques: the use of coronary ostia overlap view, the octa align technique, and the RN cusp-overlap technique.
Cerebral protection devices
19 Nov 2023 – From PCR London Valves 2023
Consult the slides on this page to analyze the use of a latest-generation cerebral protection device, observe a transcatheter mitral valve-in-valve performed with cerebral protection in a TAVR case, or appreciate the value of cerebral protection in an anomalous aortic arch.
Complex mitral interventions
19 Nov 2023 – From PCR London Valves 2023
What are the one-year outcomes of transfemoral TMVR? How does TMVI compare with SMVR in elderly patients at intermediate risk? What is the value of mitral ViV and mitral valve-in-ring in high-surgical-risk patients? Find the answers here!
CLASP IID one-year outcomes - Transcatheter edge-to-edge repair systems for degenerative MR
27 Oct 2023
Alessandro Sticchi interviews Robert L. Smith & Firas Zahr about the CLASP IID Trial and Registry which they presented during the TCT Congress 2023 in San Francisco.
The PASCAL system proved effective in treating high-risk patients with symptomatic degenerative mitral regurgitation, meeting primary and secondary endpoints while improving...

Author

Author

Author
Innovations in TAVI and mitral interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover the latest advancements in TAVI and mitral interventions in this session: discover strategies for managing non-operable cases involving triple vessel disease and severe mitral regurgitation, along with insights into tackling recurrent heart failure in patients with coronary artery and valvular heart disease, delve into the...
Coronary, structural and peripheral interventions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore the latest innovations in coronary, structural, and peripheral interventions in this session, from machine learning CT-FFR systems for severe aortic stenosis to the role of real-world data in enhancing cardiovascular care, and discover cutting-edge techniques like transpedal accesses for complex lesions and comprehensive valve sizing...